Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002. After successfully taking itraconazole, the patient developed peripheral neuropathy (tingling and loss of sensation) in the hands. After stopping itraconazole – persistent chest infections requiring antibiotics and prednisolone were common. The patient at this point had a high IgE level and positive RAST tests. Voriconazole was then prescribed – which has successfully treated the aspergillus infection – no steroids are required and the cough is greatly reduced with the patient feeling well. However an unfortunate side effect of voriconazole has been a photosensitive rash on any exposed skin. Despite using complete sunscreen – the rash continues. The patient is continuing to take voriconazole.
Share this post
Latest News posts
Aspergillosis Patient & Carer Support
June 11, 2021
How to exercise with aspergillosis
May 5, 2021
COVID Vaccination Side Effects
April 26, 2021
How to manage breathlessness
April 23, 2021
Indoor Air Quality at Home (NHS guidelines )
April 12, 2021
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video